Gain Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -0.92%
- Market cap
- $48.09M
- 44.53M shares
- Filings
- 243
FY 2023−58.4% FY23 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2024derivedN/M FY24 yoy
Q3 2026N/M FY25 yoy
Q3 2026+100.6% FY25 yoy
- $48.09M
- —
- —
- 4.7×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | $55,180 | reported | |
| FY 2022 | 2022-12-31 | $132,640 | reported | |
| FY 2021 | 2021-12-31 | $133,928 | reported | |
| FY 2020 | 2020-12-31 | $28,881 | reported |
Segments
Geography
LineFY2025ShareChange
Switzerland$253.21K49%−10.3%
Spain$252.33K49%+53.1%
United States$6.30K1.2%−40.4%
Total$511.84K
Pharmaceutical preparations
Gain Therapeutics, Inc. is the 336th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
CTORCitius Oncology, Inc.———$50.2MQUCYQuantum Cyber N.V.$537.1K39.9%3,018.3%$49.2MONCYOncolytics Biotech Inc———$49.0MHOWLWerewolf Therapeutics, Inc.———$48.3M
GANXGain Therapeutics, Inc. (this company)———$48.1M
HYFTMindWalk Holdings Corp.———$46.9MPLRXPliant Therapeutics, Inc.$0.0——$45.9MATNMActinium Pharmaceuticals, Inc.$90.0K—37,652.2%$44.8MELTXElicio Therapeutics, Inc.———$44.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Gain Therapeutics, Inc. · CIK 1819411 · Engraved from SEC EDGAR